Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2007

Open Access 01-12-2007 | Research article

Prevalence of coronary artery disease risk factors in Iran: a population based survey

Authors: ZN Hatmi, S Tahvildari, A Gafarzadeh Motlag, A Sabouri Kashani

Published in: BMC Cardiovascular Disorders | Issue 1/2007

Login to get access

Abstract

Background

Coronary artery disease (CAD) is a leading cause of mortality, morbidity, and disability with high health care cost in Iran. It accounts for nearly 50 percent of all deaths per year. Yet little is known about CAD and CAD risk factors in the Iranian population. We aimed to assess the prevalence of different CAD risk factors in an Iranian population.

Methods

A descriptive cross sectional survey was conducted involving 3000 healthy adults at 18 years of age or above who were recruited with cluster random sampling. Demographic data and risk factors were determined by taking history, physical examination and laboratory tests.

Results

The average age was 36.23 ± 15.26. There was 1381 female (46%) and 1619 male (54%) out of which 6.3% were diabetic, 21.6% were smoker, and 15% had positive familial heart disease history. 61% had total cholesterol level > 200 mg/dL, 32% triglyceride > 200 mg/dl, 47.5% LDL-c > 130 mg/dl, 5.4% HDL-c < 35 mg/dl, 13.7% systolic blood pressure > 140 mmHg, 9.1% diastolic blood pressure > 90 mmHg and 87% of them were physically inactive.

Conclusion

Clinical and Para-clinical data indicated that Iranian adult population are of a high level of CAD risk factors, which may require urgent decision making to address national control measures regarding CAD.
Literature
1.
go back to reference American Heart Association: Heart Disease and Stroke Statistics. 2006, update American Heart Association: Heart Disease and Stroke Statistics. 2006, update
2.
go back to reference Vital and Health Statistics. Series 10, July 2005. No. 225. Vital and Health Statistics. Series 10, July 2005. No. 225.
3.
go back to reference Sing RB, Tomlinson B, Neil Thomas G, Sharma R: Coronary Artery Risk Factors : The South Asia Paradox. Journal Of Nutrition and Environmental Medicine. 2001, 11: 43-51. 10.1080/13590840020030258.CrossRef Sing RB, Tomlinson B, Neil Thomas G, Sharma R: Coronary Artery Risk Factors : The South Asia Paradox. Journal Of Nutrition and Environmental Medicine. 2001, 11: 43-51. 10.1080/13590840020030258.CrossRef
4.
go back to reference Sachar R: Risk factors for coronary artery disease in young south Asians : A cross-sectional study of Indians living in India and second-generation Indian immigrants to the United States of America. 2End Year Research Elective Residents Journal. 2: 1997–1998 Sachar R: Risk factors for coronary artery disease in young south Asians : A cross-sectional study of Indians living in India and second-generation Indian immigrants to the United States of America. 2End Year Research Elective Residents Journal. 2: 1997–1998
5.
go back to reference Usman A, Frossard Philippe: Coronary heart diseasein south Asia : need to redefine risk. International Journal of Cardiology. 2006, 107 (2): 289-290. 10.1016/j.ijcard.2005.02.046.CrossRef Usman A, Frossard Philippe: Coronary heart diseasein south Asia : need to redefine risk. International Journal of Cardiology. 2006, 107 (2): 289-290. 10.1016/j.ijcard.2005.02.046.CrossRef
6.
go back to reference Hurst w: The Heart, Arteries and Veins. 2002, New York, NY: Mc GRAW – Hill, 10 Hurst w: The Heart, Arteries and Veins. 2002, New York, NY: Mc GRAW – Hill, 10
7.
go back to reference Yusuf S, Hawken S, Ounpuu S, Dans T, Dans T, Avezum A, Lanas F, Mcqueen M, Budaj A, Pais P, Varigos J, Lisheng L: Effect of potentially Modifiable Risk Factors Associated with myocardial infarction in 52 countries (the INTER HEART study): case – control study. Lancet. 2004, 364: 937-52. 10.1016/S0140-6736(04)17018-9.CrossRefPubMed Yusuf S, Hawken S, Ounpuu S, Dans T, Dans T, Avezum A, Lanas F, Mcqueen M, Budaj A, Pais P, Varigos J, Lisheng L: Effect of potentially Modifiable Risk Factors Associated with myocardial infarction in 52 countries (the INTER HEART study): case – control study. Lancet. 2004, 364: 937-52. 10.1016/S0140-6736(04)17018-9.CrossRefPubMed
8.
go back to reference Gazino JM: Global burden of cardio vascular disease. Braunwald Eugene, Heart disease a text book of cardiovascular medicine. USA. 2005, WB Saunders Company. Philadelphia, Pensylvania, 7-7 Gazino JM: Global burden of cardio vascular disease. Braunwald Eugene, Heart disease a text book of cardiovascular medicine. USA. 2005, WB Saunders Company. Philadelphia, Pensylvania, 7-7
10.
go back to reference American Heart Association: Heart and stroke facts. Dallas, American Heart Association National Center. 1992 American Heart Association: Heart and stroke facts. Dallas, American Heart Association National Center. 1992
12.
go back to reference Report of the working group on arteriosclerosis ofthe national heart, lung, and blood institute. DHEW publication No. (NIH). 1981, WASHINGTON DC, US government printing office, 2: 82-2035. Report of the working group on arteriosclerosis ofthe national heart, lung, and blood institute. DHEW publication No. (NIH). 1981, WASHINGTON DC, US government printing office, 2: 82-2035.
13.
go back to reference Stamler J: Epidemiology, established major risk factors, and the primary prevention of coronary heart disease. Cardiology. Edited by: Chatterjee K, Cheitlin MP, Karlines J. 1991, 2: 1-10.1159/000107167. Stamler J: Epidemiology, established major risk factors, and the primary prevention of coronary heart disease. Cardiology. Edited by: Chatterjee K, Cheitlin MP, Karlines J. 1991, 2: 1-10.1159/000107167.
14.
go back to reference Anderson KM, Wilson PWF, Odell PM, Kannel WB: An updated coronary risk profile: A statement for health professionals. Circulation. 1991, 83: 356-CrossRefPubMed Anderson KM, Wilson PWF, Odell PM, Kannel WB: An updated coronary risk profile: A statement for health professionals. Circulation. 1991, 83: 356-CrossRefPubMed
15.
go back to reference Braun LT, Davidson MH: Cholesterol-lowering drugs bring benefits to high risk-population even when LDL is normal. J Cardiovasc Nurs. 2003, 18 (1): 44-49.CrossRefPubMed Braun LT, Davidson MH: Cholesterol-lowering drugs bring benefits to high risk-population even when LDL is normal. J Cardiovasc Nurs. 2003, 18 (1): 44-49.CrossRefPubMed
16.
go back to reference Smith SCJR, Greenland P, Grundy SM: Prevention V report: beyond secondary prevention: identifying the high risk patient for primary prevention: executive summary. Circulation. 2000, 101: 111-116.CrossRefPubMed Smith SCJR, Greenland P, Grundy SM: Prevention V report: beyond secondary prevention: identifying the high risk patient for primary prevention: executive summary. Circulation. 2000, 101: 111-116.CrossRefPubMed
17.
go back to reference Kanala KR, Reddy FOCN, Rao Alahari, Reddy Thavanati: Socioeconomic status and the prevalence of coronary heart disease risk factors. Asia Pacific Journal of Clinical Nutrition. 2002, 11: 98-10.1046/j.1440-6047.2002.00267.x.CrossRef Kanala KR, Reddy FOCN, Rao Alahari, Reddy Thavanati: Socioeconomic status and the prevalence of coronary heart disease risk factors. Asia Pacific Journal of Clinical Nutrition. 2002, 11: 98-10.1046/j.1440-6047.2002.00267.x.CrossRef
18.
go back to reference Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby p, Galimore JR, Pepys MB: Low grade inflammation and coronary heart disease: prospective study and updated meta- analysis. BMJ. 2000, 321: 199-204. 10.1136/bmj.321.7255.199.CrossRefPubMedPubMedCentral Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby p, Galimore JR, Pepys MB: Low grade inflammation and coronary heart disease: prospective study and updated meta- analysis. BMJ. 2000, 321: 199-204. 10.1136/bmj.321.7255.199.CrossRefPubMedPubMedCentral
19.
20.
go back to reference Choi KM, Lee J, Kim YU, Danesh J, Wheeler JG, Hirschfield GM: C- reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004, 350 (14): 1387-1397. 10.1056/NEJMoa032804.CrossRef Choi KM, Lee J, Kim YU, Danesh J, Wheeler JG, Hirschfield GM: C- reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004, 350 (14): 1387-1397. 10.1056/NEJMoa032804.CrossRef
21.
go back to reference Expert panel on detection, Evaluation and treatment of high blood cholesterol in adults: Executive summary o the third report of the national cholesterol education program (NCEP) – adult treatment panel III (ATPIII). Jama. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486. Expert panel on detection, Evaluation and treatment of high blood cholesterol in adults: Executive summary o the third report of the national cholesterol education program (NCEP) – adult treatment panel III (ATPIII). Jama. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.
22.
go back to reference Ridker PM, Rafie N, Lowenthal SP: Rapid reduction in c- reactive protein with CERIVASTATIN among 785 patients with primary hypercholesterolemia. Circulation. 2001, 103 (9): 1191-1193.CrossRefPubMed Ridker PM, Rafie N, Lowenthal SP: Rapid reduction in c- reactive protein with CERIVASTATIN among 785 patients with primary hypercholesterolemia. Circulation. 2001, 103 (9): 1191-1193.CrossRefPubMed
Metadata
Title
Prevalence of coronary artery disease risk factors in Iran: a population based survey
Authors
ZN Hatmi
S Tahvildari
A Gafarzadeh Motlag
A Sabouri Kashani
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2007
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/1471-2261-7-32

Other articles of this Issue 1/2007

BMC Cardiovascular Disorders 1/2007 Go to the issue